US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Beyondspring Inc

0.6222

+0.01121.83%

Post-market: 0.6120-0.0102-1.64%19:42 EDT

Volume:43.68K

Turnover:28.19K

Market Cap:25.59M

PE:-3.80

High:0.6499

Open:0.6410

Low:0.6221

Close:0.6110

52wk High:2.44

52wk Low:0.5657

Shares:41.12M

Float Shares:31.95M

Volume Ratio:0.39

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1638

EPS(LYR):-0.0249

ROE:-310.48%

ROA:-22.86%

PB:-0.72

PE(LYR):-24.99

Loading ...

Overview Company News Filings

BeyondSpring says Phase 2 trial shows 7-month median PFS for pembrolizumab plus plinabulin/docetaxel in post-ICI metastatic NSCLC

BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026

BeyondSpring to present Phase 2 plinabulin combo study in resistant NSCLC at ASCO 2026

BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting

BeyondSpring Q1 EPS $(0.05) Up From $(0.06) YoY

Benzinga Earnings

BeyondSpring Q1 FY26 net loss narrows to $2.4 million

BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update

BeyondSpring publishes corporate presentation on plinabulin immune-modulating cancer therapy pipeline

BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

BeyondSpring to present plinabulin-ADC combination data at AACR annual meeting poster session

BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026

BeyondSpring publishes IO360 Summit presentation on plinabulin; PD-1/L1 resistance highlighted

BeyondSpring publishes corporate presentation; plinabulin clinical program advances and SEED targeted protein degradation pipeline grows

BeyondSpring FY2025 net loss drops 15% to $14 million; research and development expenses climb 66% to $4 million

BeyondSpring Files 2025 Annual Report on Form 10-K

BeyondSpring Q4 EPS $(0.05)

Benzinga Earnings

BeyondSpring FY2025 operating loss narrows 2.25% to $8.7 million; R&D expenses jump 69.23% to $4.4 million

Beyondspring Reports 2025 Year-End Financial Results

THOMSON REUTERS

Press Release: BeyondSpring Reports 2025 Year-End Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/BYSI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BYSI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BYSI\",,,,,undefined,":{"symbol":"BYSI","market":"US","secType":"STK","nameCN":"Beyondspring Inc","latestPrice":0.6222,"timestamp":1788465600000,"preClose":0.611,"halted":0,"volume":43683,"hourTrading":{"tag":"盘后","latestPrice":0.612,"preClose":0.6222,"latestTime":"19:42 EDT","volume":1389,"amount":852.0696,"timestamp":1788478955632,"change":-0.0102,"changeRate":-0.016393,"amplitude":0.016393},"delay":0,"changeRate":0.0183306055646481,"floatShares":31950100,"shares":41122299,"eps":-0.163815,"marketStatus":"Closed","change":0.0112,"latestTime":"09-03 16:00:00 EDT","open":0.641,"high":0.6499,"low":0.6221,"amount":28190.8764696,"amplitude":0.045499,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.163815,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788508800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1489035600000,"exchange":"NASDAQ","adjPreClose":0.611,"preHourTrading":{"tag":"盘前","latestPrice":0.619,"preClose":0.611,"latestTime":"09:29 EDT","volume":13643,"amount":8965.240143019999,"timestamp":1788442199999,"change":0.008,"changeRate":0.013093,"amplitude":0.216858},"postHourTrading":{"tag":"盘后","latestPrice":0.612,"preClose":0.6222,"latestTime":"19:42 EDT","volume":1389,"amount":852.0696,"timestamp":1788478955632,"change":-0.0102,"changeRate":-0.016393,"amplitude":0.016393},"volumeRatio":0.389502,"impliedVol":0.4474,"impliedVolPercentile":0.8571},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BYSI\",,,,,undefined,":{"symbol":"BYSI","floatShares":31950100,"roa":"-22.86%","roe":"-310.48%","lyrEps":-0.024897,"volumeRatio":0.389502,"shares":41122299,"dividePrice":0,"high":0.6499,"amplitude":0.045499,"preClose":0.611,"low":0.6221,"week52Low":0.5657,"pbRate":"-0.72","psRate":"13.64","week52High":2.44,"institutionHeld":0,"latestPrice":0.6222,"eps":-0.163815,"divideRate":0,"volume":43683,"delay":0,"ttmEps":-0.163815,"open":0.641,"prevYearClose":1.63,"prevWeekClose":0.6654,"prevMonthClose":0.6205,"prevQuarterClose":1.75,"fiveDayClose":0.6402,"twentyDayClose":0.87,"sixtyDayClose":1.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BYSI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"BYSI","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2026-05-13","symbol":"BYSI","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.05},{"date":"2026-03-25","symbol":"BYSI","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774425600000,"name":null,"time":"Pre-MKt","dateTimestamp":1774411200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"BYSI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-08-13","symbol":"BYSI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BYSI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BYSI\",market:\"US\",delay:true,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BYSI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"BYSI","date":"2026-09-02","current":-3.798187,"percent":0.508828,"low":-161.60109,"twenty":-19.691837,"median":-3.98705,"eighty":-1.061308,"high":-0.342396,"avg":-17.216667,"sd":32.48593,"marketCap":24778803},"quantilePoints":[{"date":"2021-09-03","current":-16.962972,"twenty":-11.306172,"median":-8.751794,"eighty":-7.267265,"marketCap":1049617815},{"date":"2021-09-10","current":-13.969717,"twenty":-11.349009,"median":-8.774324,"eighty":-7.276775,"marketCap":955975683},{"date":"2021-09-17","current":-13.095181,"twenty":-11.577555,"median":-8.780006,"eighty":-7.277247,"marketCap":896129415},{"date":"2021-09-24","current":-8.81967,"twenty":-11.511898,"median":-8.779659,"eighty":-7.279472,"marketCap":603547659},{"date":"2021-10-01","current":-8.796806,"twenty":-11.414906,"median":-8.784917,"eighty":-7.280852,"marketCap":601983051},{"date":"2021-10-08","current":-8.551022,"twenty":-11.373288,"median":-8.775305,"eighty":-7.283325,"marketCap":585163511},{"date":"2021-10-15","current":-9.459853,"twenty":-11.349009,"median":-8.782183,"eighty":-7.290009,"marketCap":647356692},{"date":"2021-10-22","current":-9.139762,"twenty":-11.329516,"median":-8.789263,"eighty":-7.2923,"marketCap":625452175},{"date":"2021-10-29","current":-7.899406,"twenty":-11.307631,"median":-8.784917,"eighty":-7.297158,"marketCap":540572174},{"date":"2021-11-05","current":-8.676772,"twenty":-11.307631,"median":-8.784707,"eighty":-7.297158,"marketCap":593768857},{"date":"2021-11-12","current":-8.459567,"twenty":-11.300335,"median":-8.777482,"eighty":-7.330781,"marketCap":578905078},{"date":"2021-11-19","current":-7.573599,"twenty":-11.300335,"median":-8.774324,"eighty":-7.333884,"marketCap":518276506},{"date":"2021-11-26","current":-8.20235,"twenty":-11.294499,"median":-8.764743,"eighty":-7.333263,"marketCap":561303234},{"date":"2021-12-03","current":-2.297801,"twenty":-11.29304,"median":-8.74476,"eighty":-7.297158,"marketCap":157243136},{"date":"2021-12-10","current":-2.389256,"twenty":-11.279239,"median":-8.735735,"eighty":-7.28283,"marketCap":163501569},{"date":"2021-12-17","current":-2.617893,"twenty":-11.184539,"median":-8.732706,"eighty":-7.274397,"marketCap":179147652},{"date":"2021-12-23","current":-2.812234,"twenty":-11.15548,"median":-8.724843,"eighty":-7.260231,"marketCap":192446823},{"date":"2021-12-31","current":-2.453771,"twenty":-11.148807,"median":-8.714589,"eighty":-7.243476,"marketCap":177314406},{"date":"2022-01-07","current":-2.453771,"twenty":-11.125249,"median":-8.713986,"eighty":-7.235633,"marketCap":177314406},{"date":"2022-01-14","current":-2.101685,"twenty":-11.106282,"median":-8.69392,"eighty":-7.22882,"marketCap":151871941},{"date":"2022-01-21","current":-1.776682,"twenty":-11.102292,"median":-8.693667,"eighty":-7.22195,"marketCap":128386589},{"date":"2022-01-28","current":-1.630431,"twenty":-11.090084,"median":-8.682709,"eighty":-7.20706,"marketCap":117818181},{"date":"2022-02-04","current":-1.662931,"twenty":-11.062511,"median":-8.676855,"eighty":-7.172414,"marketCap":120166716},{"date":"2022-02-11","current":-1.608764,"twenty":-11.029242,"median":-8.675168,"eighty":-7.155129,"marketCap":116252491},{"date":"2022-02-18","current":-1.435429,"twenty":-11.005487,"median":-8.659624,"eighty":-7.143917,"marketCap":103726970},{"date":"2022-02-25","current":-1.365012,"twenty":-11.004497,"median":-8.641816,"eighty":-7.109794,"marketCap":98638477},{"date":"2022-03-04","current":-1.077926,"twenty":-10.998539,"median":-8.624931,"eighty":-7.072868,"marketCap":77893083},{"date":"2022-03-11","current":-1.007509,"twenty":-10.983171,"median":-8.613897,"eighty":-7.046745,"marketCap":72804590},{"date":"2022-03-18","current":-1.251261,"twenty":-10.963416,"median":-8.59976,"eighty":-6.999757,"marketCap":90418604},{"date":"2022-03-25","current":-1.20251,"twenty":-10.956482,"median":-8.596563,"eighty":-6.97543,"marketCap":86895801},{"date":"2022-04-01","current":-1.300011,"twenty":-10.947277,"median":-8.592937,"eighty":-6.930407,"marketCap":93941407},{"date":"2022-04-08","current":-1.283761,"twenty":-10.934968,"median":-8.577836,"eighty":-6.887865,"marketCap":92767139},{"date":"2022-04-14","current":-1.328337,"twenty":-10.931928,"median":-8.571023,"eighty":-6.881827,"marketCap":85251362},{"date":"2022-04-22","current":-1.182766,"twenty":-10.874867,"median":-8.55388,"eighty":-6.862586,"marketCap":75908747},{"date":"2022-04-29","current":-0.921951,"twenty":-10.869132,"median":-8.543875,"eighty":-6.844639,"marketCap":59169895},{"date":"2022-05-06","current":-0.97654,"twenty":-10.799881,"median":-8.518237,"eighty":-6.824288,"marketCap":62673376},{"date":"2022-05-13","current":-0.758183,"twenty":-10.793266,"median":-8.475943,"eighty":-6.802132,"marketCap":48659453},{"date":"2022-05-20","current":-0.782445,"twenty":-10.757701,"median":-8.440174,"eighty":-6.794418,"marketCap":50216556},{"date":"2022-05-27","current":-0.800642,"twenty":-10.666331,"median":-8.417431,"eighty":-6.777322,"marketCap":51384383},{"date":"2022-06-03","current":-0.964409,"twenty":-10.593851,"median":-8.40388,"eighty":-6.766317,"marketCap":61894825},{"date":"2022-06-10","current":-1.073588,"twenty":-10.535211,"median":-8.379544,"eighty":-6.743515,"marketCap":68901786},{"date":"2022-06-17","current":-0.8431,"twenty":-10.485959,"median":-8.340934,"eighty":-6.72321,"marketCap":54109312},{"date":"2022-06-24","current":-0.8431,"twenty":-10.428365,"median":-8.316315,"eighty":-6.693158,"marketCap":54109312},{"date":"2022-07-01","current":-0.946213,"twenty":-10.400502,"median":-8.301716,"eighty":-6.672201,"marketCap":60726998},{"date":"2022-07-08","current":-1.09785,"twenty":-10.388718,"median":-8.29285,"eighty":-6.654109,"marketCap":70458889},{"date":"2022-07-15","current":-0.970475,"twenty":-10.36542,"median":-8.27886,"eighty":-6.644132,"marketCap":62284100},{"date":"2022-07-22","current":-0.8431,"twenty":-10.301418,"median":-8.238859,"eighty":-6.618151,"marketCap":54109312},{"date":"2022-07-29","current":-0.8431,"twenty":-10.252094,"median":-8.216736,"eighty":-6.607281,"marketCap":54109312},{"date":"2022-08-05","current":-0.915886,"twenty":-10.210516,"median":-8.20235,"eighty":-6.590159,"marketCap":58780620},{"date":"2022-08-12","current":-0.964409,"twenty":-10.173794,"median":-8.18979,"eighty":-6.556471,"marketCap":61894825},{"date":"2022-08-19","current":-0.946213,"twenty":-10.154544,"median":-8.161715,"eighty":-6.517533,"marketCap":60726998},{"date":"2022-08-26","current":-0.806707,"twenty":-10.091811,"median":-8.14509,"eighty":-6.480049,"marketCap":51773658},{"date":"2022-09-02","current":-0.770314,"twenty":-10.001482,"median":-8.100262,"eighty":-6.450482,"marketCap":49438005},{"date":"2022-09-09","current":-0.940147,"twenty":-9.993794,"median":-8.075287,"eighty":-6.419817,"marketCap":60337722},{"date":"2022-09-16","current":-0.830969,"twenty":-9.971244,"median":-8.054429,"eighty":-6.391117,"marketCap":53330761},{"date":"2022-09-23","current":-0.64294,"twenty":-9.950155,"median":-8.021655,"eighty":-6.338172,"marketCap":41263216},{"date":"2022-09-30","current":-0.600481,"twenty":-9.913473,"median":-8.015173,"eighty":-6.301074,"marketCap":38538287},{"date":"2022-10-07","current":-0.590595,"twenty":-9.889115,"median":-7.97709,"eighty":-6.254861,"marketCap":37903768},{"date":"2022-10-14","current":-0.521812,"twenty":-9.850961,"median":-7.945258,"eighty":-6.207183,"marketCap":33489382},{"date":"2022-10-21","current":-0.491849,"twenty":-9.81876,"median":-7.926159,"eighty":-6.166303,"marketCap":31566360},{"date":"2022-10-28","current":-0.485237,"twenty":-9.793262,"median":-7.900693,"eighty":-6.152974,"marketCap":31142050},{"date":"2022-11-04","current":-0.441141,"twenty":-9.758343,"median":-7.867886,"eighty":-6.122096,"marketCap":28312016},{"date":"2022-11-11","current":-0.424583,"twenty":-9.733956,"median":-7.829624,"eighty":-6.083665,"marketCap":27249294},{"date":"2022-11-18","current":-0.387401,"twenty":-9.705595,"median":-7.81793,"eighty":-5.903749,"marketCap":24863034},{"date":"2022-11-25","current":-0.361684,"twenty":-9.686755,"median":-7.810813,"eighty":-5.7831,"marketCap":23212505},{"date":"2022-12-02","current":-0.347127,"twenty":-9.682822,"median":-7.771856,"eighty":-2.793943,"marketCap":22278244},{"date":"2022-12-09","current":-0.369994,"twenty":-9.682822,"median":-7.746125,"eighty":-2.621323,"marketCap":23745813},{"date":"2022-12-16","current":-1.382927,"twenty":-9.682822,"median":-7.73971,"eighty":-2.570308,"marketCap":88754843},{"date":"2022-12-23","current":-1.025064,"twenty":-9.677099,"median":-7.719207,"eighty":-2.463076,"marketCap":65787581},{"date":"2022-12-30","current":-1.140308,"twenty":-9.677099,"median":-7.706017,"eighty":-2.431933,"marketCap":73183818},{"date":"2023-01-06","current":-1.055391,"twenty":-9.677099,"median":-7.684438,"eighty":-2.36321,"marketCap":67733959},{"date":"2023-01-13","current":-1.29801,"twenty":-9.677099,"median":-7.671666,"eighty":-2.219355,"marketCap":83304984},{"date":"2023-01-20","current":-1.516367,"twenty":-9.677099,"median":-7.671666,"eighty":-1.914266,"marketCap":97318907},{"date":"2023-01-27","current":-1.534563,"twenty":-9.670972,"median":-7.643672,"eighty":-1.765848,"marketCap":98486734},{"date":"2023-02-03","current":-1.637676,"twenty":-9.670972,"median":-7.624089,"eighty":-1.683515,"marketCap":105104420},{"date":"2023-02-10","current":-1.352599,"twenty":-9.670972,"median":-7.620572,"eighty":-1.662931,"marketCap":86808465},{"date":"2023-02-17","current":-1.23129,"twenty":-9.670972,"median":-7.620572,"eighty":-1.623166,"marketCap":79022952},{"date":"2023-02-24","current":-1.152439,"twenty":-9.670972,"median":-7.620572,"eighty":-1.606597,"marketCap":73962369},{"date":"2023-03-03","current":-1.570917,"twenty":-9.670972,"median":-7.620572,"eighty":-1.580661,"marketCap":72846553},{"date":"2023-03-10","current":-1.201289,"twenty":-9.670972,"median":-7.610609,"eighty":-1.558614,"marketCap":55706187},{"date":"2023-03-17","current":-1.041677,"twenty":-9.670972,"median":-7.590746,"eighty":-1.531324,"marketCap":48304666},{"date":"2023-03-24","current":-0.898867,"twenty":-9.670972,"median":-7.586599,"eighty":-1.45222,"marketCap":41682252},{"date":"2023-03-31","current":-0.94087,"twenty":-9.669751,"median":-7.58433,"eighty":-1.382927,"marketCap":43630021},{"date":"2023-04-06","current":-0.890466,"twenty":-9.669751,"median":-7.582522,"eighty":-1.36419,"marketCap":41292698},{"date":"2023-04-14","current":-1.008075,"twenty":-9.670972,"median":-7.582522,"eighty":-1.323507,"marketCap":46746451},{"date":"2023-04-21","current":-1.253931,"twenty":-9.670972,"median":-7.582522,"eighty":-1.308256,"marketCap":41729568},{"date":"2023-04-28","current":-1.125022,"twenty":-9.670972,"median":-7.570231,"eighty":-1.293534,"marketCap":37439613},{"date":"2023-05-05","current":-1.054708,"twenty":-9.670972,"median":-7.56517,"eighty":-1.262094,"marketCap":35099637},{"date":"2023-05-12","current":-1.183617,"twenty":-9.670972,"median":-7.56517,"eighty":-1.252863,"marketCap":39389592},{"date":"2023-05-19","current":-1.207055,"twenty":-9.670972,"median":-7.56517,"eighty":-1.240995,"marketCap":40169584},{"date":"2023-05-26","current":-1.218774,"twenty":-9.670972,"median":-7.56447,"eighty":-1.236417,"marketCap":40559580},{"date":"2023-06-02","current":-1.26565,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":42119564},{"date":"2023-06-09","current":-1.417997,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":47189512},{"date":"2023-06-16","current":-1.406278,"twenty":-9.670972,"median":-7.56447,"eighty":-1.228445,"marketCap":46799516},{"date":"2023-06-23","current":-1.406278,"twenty":-9.666612,"median":-7.558062,"eighty":-1.2256,"marketCap":46799516},{"date":"2023-06-30","current":-1.488311,"twenty":-9.625615,"median":-7.541992,"eighty":-1.224177,"marketCap":49529488},{"date":"2023-07-07","current":-1.324245,"twenty":-9.59294,"median":-7.541173,"eighty":-1.224177,"marketCap":44069544},{"date":"2023-07-14","current":-1.324245,"twenty":-9.527072,"median":-7.523385,"eighty":-1.224177,"marketCap":44069544},{"date":"2023-07-21","current":-1.26565,"twenty":-9.498536,"median":-7.491871,"eighty":-1.224177,"marketCap":42119564},{"date":"2023-07-28","current":-1.195336,"twenty":-9.463887,"median":-7.460598,"eighty":-1.218774,"marketCap":39779588},{"date":"2023-08-04","current":-1.183617,"twenty":-9.434142,"median":-7.43501,"eighty":-1.207055,"marketCap":39389592},{"date":"2023-08-11","current":-1.160179,"twenty":-9.407958,"median":-7.3852,"eighty":-1.201289,"marketCap":38609601},{"date":"2023-08-18","current":-1.14846,"twenty":-9.407958,"median":-7.378691,"eighty":-1.195336,"marketCap":38219605},{"date":"2023-08-25","current":-1.089865,"twenty":-9.407958,"median":-7.362612,"eighty":-1.188832,"marketCap":36269625},{"date":"2023-09-01","current":-1.054708,"twenty":-9.407958,"median":-7.356852,"eighty":-1.183617,"marketCap":35099637},{"date":"2023-09-08","current":-1.078146,"twenty":-9.407958,"median":-7.342021,"eighty":-1.183617,"marketCap":35879629},{"date":"2023-09-15","current":-1.03127,"twenty":-9.34521,"median":-7.337925,"eighty":-1.171898,"marketCap":34319645},{"date":"2023-09-22","current":-0.972675,"twenty":-9.313335,"median":-7.297158,"eighty":-1.16457,"marketCap":32369665},{"date":"2023-09-29","current":-0.874822,"twenty":-9.240982,"median":-7.27836,"eighty":-1.151741,"marketCap":29113199},{"date":"2023-10-06","current":-0.91033,"twenty":-9.217485,"median":-7.259591,"eighty":-1.140308,"marketCap":30294886},{"date":"2023-10-13","current":-1.253931,"twenty":-9.205804,"median":-7.239403,"eighty":-1.1351,"marketCap":41729568},{"date":"2023-10-20","current":-1.218774,"twenty":-9.205804,"median":-7.235538,"eighty":-1.1351,"marketCap":40559580},{"date":"2023-10-27","current":-1.242212,"twenty":-9.209208,"median":-7.224676,"eighty":-1.13503,"marketCap":41339572},{"date":"2023-11-03","current":-1.078146,"twenty":-9.209208,"median":-7.208286,"eighty":-1.134538,"marketCap":35879629},{"date":"2023-11-10","current":-1.088107,"twenty":-9.209208,"median":-7.17486,"eighty":-1.125022,"marketCap":36211125},{"date":"2023-11-17","current":-1.094553,"twenty":-9.209208,"median":-7.14828,"eighty":-1.1144,"marketCap":36425623},{"date":"2023-11-24","current":-1.019551,"twenty":-9.147917,"median":-7.103719,"eighty":-1.109232,"marketCap":33929649},{"date":"2023-12-01","current":-1.001973,"twenty":-9.109429,"median":-7.053158,"eighty":-1.095491,"marketCap":33344655},{"date":"2023-12-08","current":-1.03127,"twenty":-9.097201,"median":-7.003635,"eighty":-1.088733,"marketCap":34319645},{"date":"2023-12-15","current":-1.089865,"twenty":-9.091899,"median":-6.948878,"eighty":-1.087152,"marketCap":36269625},{"date":"2023-12-22","current":-1.066427,"twenty":-9.091899,"median":-6.885419,"eighty":-1.081608,"marketCap":35489633},{"date":"2023-12-29","current":-1.028927,"twenty":-9.093583,"median":-6.875377,"eighty":-1.078076,"marketCap":34241646},{"date":"2024-01-05","current":-1.054708,"twenty":-9.095268,"median":-6.858339,"eighty":-1.077926,"marketCap":35099637},{"date":"2024-01-12","current":-0.996349,"twenty":-9.095268,"median":-6.840522,"eighty":-1.074265,"marketCap":33157496},{"date":"2024-01-19","current":-1.054708,"twenty":-9.096952,"median":-6.803887,"eighty":-1.066427,"marketCap":35099637},{"date":"2024-01-26","current":-1.043106,"twenty":-9.095268,"median":-6.79162,"eighty":-1.061982,"marketCap":34713541},{"date":"2024-02-02","current":-1.171898,"twenty":-9.095268,"median":-6.751703,"eighty":-1.061982,"marketCap":38999597},{"date":"2024-02-09","current":-1.623872,"twenty":-9.095268,"median":-6.670796,"eighty":-1.061982,"marketCap":44672720},{"date":"2024-02-16","current":-1.942974,"twenty":-9.095268,"median":-6.639575,"eighty":-1.061982,"marketCap":53451202},{"date":"2024-02-23","current":-1.517505,"twenty":-9.095268,"median":-6.607596,"eighty":-1.061982,"marketCap":41746559},{"date":"2024-03-01","current":-1.886244,"twenty":-9.093583,"median":-6.55367,"eighty":-1.062507,"marketCap":51890583},{"date":"2024-03-08","current":-4.21214,"twenty":-9.093583,"median":-6.502965,"eighty":-1.062507,"marketCap":115875963},{"date":"2024-03-15","current":-4.112864,"twenty":-9.093583,"median":-6.458528,"eighty":-1.062507,"marketCap":113144880},{"date":"2024-03-22","current":-4.226322,"twenty":-9.093583,"median":-6.420725,"eighty":-1.062507,"marketCap":116266118},{"date":"2024-03-28","current":-5.148171,"twenty":-9.093583,"median":-6.400805,"eighty":-1.062507,"marketCap":141626177},{"date":"2024-04-05","current":-3.687395,"twenty":-9.095268,"median":-6.347041,"eighty":-1.061982,"marketCap":101440237},{"date":"2024-04-12","current":-2.921551,"twenty":-9.095268,"median":-6.303807,"eighty":-1.061982,"marketCap":80371880},{"date":"2024-04-19","current":-2.552812,"twenty":-9.095268,"median":-6.283707,"eighty":-1.061982,"marketCap":70227856},{"date":"2024-04-26","current":-3.219379,"twenty":-9.093583,"median":-6.26634,"eighty":-1.062507,"marketCap":88565130},{"date":"2024-05-03","current":-3.063516,"twenty":-9.093583,"median":-6.253291,"eighty":-1.062507,"marketCap":84277329},{"date":"2024-05-10","current":-3.304473,"twenty":-9.093583,"median":-6.253291,"eighty":-1.062507,"marketCap":90906059},{"date":"2024-05-17","current":-4.022089,"twenty":-9.093583,"median":-6.162033,"eighty":-1.062507,"marketCap":110647677},{"date":"2024-05-24","current":-6.36688,"twenty":-9.093583,"median":-6.150673,"eighty":-1.062507,"marketCap":133870029},{"date":"2024-05-31","current":-4.881894,"twenty":-9.093583,"median":-6.111473,"eighty":-1.062507,"marketCap":102646698},{"date":"2024-06-07","current":-4.529209,"twenty":-9.093583,"median":-5.991392,"eighty":-1.062507,"marketCap":95231157},{"date":"2024-06-14","current":-4.900456,"twenty":-9.093583,"median":-5.119806,"eighty":-1.062507,"marketCap":103036990},{"date":"2024-06-21","current":-4.69627,"twenty":-9.065467,"median":-5.074578,"eighty":-1.061982,"marketCap":98743782},{"date":"2024-06-28","current":-4.45496,"twenty":-9.049757,"median":-4.938699,"eighty":-1.061982,"marketCap":93669991},{"date":"2024-07-05","current":-4.547772,"twenty":-9.034297,"median":-4.866118,"eighty":-1.061982,"marketCap":95621449},{"date":"2024-07-12","current":-4.343586,"twenty":-9.027495,"median":-4.646187,"eighty":-1.061982,"marketCap":91328241},{"date":"2024-07-19","current":-4.083713,"twenty":-9.008296,"median":-4.566515,"eighty":-1.061982,"marketCap":85864158},{"date":"2024-07-26","current":-3.647499,"twenty":-9.008296,"median":-4.482804,"eighty":-1.061982,"marketCap":76692305},{"date":"2024-08-02","current":-3.434032,"twenty":-9.005363,"median":-4.402793,"eighty":-1.061982,"marketCap":72203951},{"date":"2024-08-09","current":-3.601093,"twenty":-8.998216,"median":-4.325024,"eighty":-1.061982,"marketCap":75716576},{"date":"2024-08-16","current":-3.471156,"twenty":-8.984285,"median":-4.268869,"eighty":-1.061982,"marketCap":72984534},{"date":"2024-08-23","current":-3.563968,"twenty":-8.966097,"median":-4.219986,"eighty":-1.061982,"marketCap":74935992},{"date":"2024-08-30","current":-5.280878,"twenty":-8.938391,"median":-4.194332,"eighty":-1.061982,"marketCap":82212714},{"date":"2024-09-06","current":-5.099672,"twenty":-8.913084,"median":-4.194332,"eighty":-1.061982,"marketCap":79391689},{"date":"2024-09-13","current":-5.953931,"twenty":-8.88535,"median":-4.194332,"eighty":-1.061982,"marketCap":92690805},{"date":"2024-09-20","current":-5.513858,"twenty":-8.862512,"median":-4.194332,"eighty":-1.061982,"marketCap":85839745},{"date":"2024-09-27","current":-5.695065,"twenty":-8.83563,"median":-4.194332,"eighty":-1.061982,"marketCap":88660770},{"date":"2024-10-04","current":-6.135138,"twenty":-8.820265,"median":-4.194332,"eighty":-1.061982,"marketCap":95511829},{"date":"2024-10-11","current":-6.445778,"twenty":-8.804634,"median":-4.194332,"eighty":-1.061982,"marketCap":100347871},{"date":"2024-10-18","current":-6.057478,"twenty":-8.774324,"median":-4.194332,"eighty":-1.061982,"marketCap":94302819},{"date":"2024-10-25","current":-5.850385,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":91078791},{"date":"2024-11-01","current":-5.772725,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":89869780},{"date":"2024-11-08","current":-5.022012,"twenty":-8.734517,"median":-4.194332,"eighty":-1.061982,"marketCap":78182679},{"date":"2024-11-15","current":-4.193639,"twenty":-8.734517,"median":-4.185082,"eighty":-1.061982,"marketCap":65286567},{"date":"2024-11-22","current":-4.504279,"twenty":-8.725745,"median":-4.185082,"eighty":-1.061982,"marketCap":70122609},{"date":"2024-11-29","current":-4.996125,"twenty":-8.713034,"median":-4.185082,"eighty":-1.061982,"marketCap":77779675},{"date":"2024-12-06","current":-4.400732,"twenty":-8.69392,"median":-4.185082,"eighty":-1.061982,"marketCap":68510595},{"date":"2024-12-13","current":-4.245412,"twenty":-8.668422,"median":-4.173059,"eighty":-1.061982,"marketCap":66092574},{"date":"2024-12-20","current":-4.115979,"twenty":-8.623519,"median":-4.114422,"eighty":-1.061982,"marketCap":64077556},{"date":"2024-12-27","current":-4.180695,"twenty":-8.596523,"median":-4.114422,"eighty":-1.061982,"marketCap":65085065},{"date":"2025-01-03","current":-4.219525,"twenty":-8.568166,"median":-4.114422,"eighty":-1.061982,"marketCap":65689570},{"date":"2025-01-10","current":-4.297185,"twenty":-8.543875,"median":-4.112864,"eighty":-1.061457,"marketCap":66898581},{"date":"2025-01-17","current":-4.452505,"twenty":-8.475638,"median":-4.112864,"eighty":-1.061457,"marketCap":69316602},{"date":"2025-01-24","current":-4.426619,"twenty":-8.440174,"median":-4.112864,"eighty":-1.061457,"marketCap":68913598},{"date":"2025-01-31","current":-4.633712,"twenty":-8.413839,"median":-4.112864,"eighty":-1.061457,"marketCap":72137626},{"date":"2025-02-07","current":-4.323072,"twenty":-8.379544,"median":-4.112864,"eighty":-1.061457,"marketCap":67301584},{"date":"2025-02-14","current":-4.426877,"twenty":-8.325638,"median":-4.112864,"eighty":-1.061457,"marketCap":68917628},{"date":"2025-02-21","current":-4.633712,"twenty":-8.280104,"median":-4.112864,"eighty":-1.061457,"marketCap":72137626},{"date":"2025-02-28","current":-4.374845,"twenty":-8.216736,"median":-4.112864,"eighty":-1.061457,"marketCap":68107591},{"date":"2025-03-07","current":-4.323072,"twenty":-8.165465,"median":-4.112864,"eighty":-1.06142,"marketCap":67301584},{"date":"2025-03-14","current":-4.505832,"twenty":-8.144499,"median":-4.112864,"eighty":-1.06142,"marketCap":70146789},{"date":"2025-03-21","current":-4.141865,"twenty":-8.099624,"median":-4.112864,"eighty":-1.06142,"marketCap":64480560},{"date":"2025-03-28","current":-5.21941,"twenty":-8.029949,"median":-4.052901,"eighty":-1.06142,"marketCap":58055500},{"date":"2025-04-04","current":-4.856951,"twenty":-7.975726,"median":-4.052901,"eighty":-1.06142,"marketCap":54023868},{"date":"2025-04-11","current":-3.98705,"twenty":-7.904381,"median":-4.017609,"eighty":-1.061457,"marketCap":44347952},{"date":"2025-04-17","current":-4.748214,"twenty":-7.829624,"median":-4.017609,"eighty":-1.061457,"marketCap":52814379},{"date":"2025-04-25","current":-5.799345,"twenty":-7.762945,"median":-4.016303,"eighty":-1.06142,"marketCap":64506112},{"date":"2025-05-02","current":-6.125558,"twenty":-7.734259,"median":-4.016303,"eighty":-1.06142,"marketCap":68134580},{"date":"2025-05-09","current":-6.089312,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-05-16","current":-19.597391,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":66925091},{"date":"2025-05-23","current":-19.833504,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-05-30","current":-20.561913,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":70218934},{"date":"2025-06-06","current":-19.833504,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":67731417},{"date":"2025-06-13","current":-33.41001,"twenty":-7.699298,"median":-4.016303,"eighty":-1.06142,"marketCap":114095185},{"date":"2025-06-20","current":-36.715594,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":125383755},{"date":"2025-06-27","current":-29.750257,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":101597126},{"date":"2025-07-03","current":-26.326616,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":89905393},{"date":"2025-07-11","current":-26.562729,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":90711720},{"date":"2025-07-18","current":-25.972446,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":88695904},{"date":"2025-07-25","current":-23.021032,"twenty":-7.680435,"median":-4.014996,"eighty":-1.061383,"marketCap":78616824},{"date":"2025-08-01","current":-24.201598,"twenty":-7.735622,"median":-4.014996,"eighty":-1.061383,"marketCap":82648456},{"date":"2025-08-08","current":-24.087125,"twenty":-7.765539,"median":-4.014996,"eighty":-1.061383,"marketCap":82257532},{"date":"2025-08-15","current":-68.124339,"twenty":-7.829624,"median":-4.014996,"eighty":-1.061383,"marketCap":81067963},{"date":"2025-08-22","current":-59.651162,"twenty":-7.867699,"median":-4.014996,"eighty":-1.061383,"marketCap":70984883},{"date":"2025-08-29","current":-61.006871,"twenty":-7.942625,"median":-4.014996,"eighty":-1.061383,"marketCap":72598176},{"date":"2025-09-05","current":-62.362578,"twenty":-8.008083,"median":-4.013714,"eighty":-1.061345,"marketCap":74211468},{"date":"2025-09-12","current":-63.37936,"twenty":-8.051793,"median":-4.014996,"eighty":-1.061383,"marketCap":75421438},{"date":"2025-09-19","current":-58.295454,"twenty":-8.051793,"median":-4.014996,"eighty":-1.061383,"marketCap":69371590},{"date":"2025-09-26","current":-56.939745,"twenty":-8.138933,"median":-4.014996,"eighty":-1.061383,"marketCap":67758297},{"date":"2025-10-03","current":-58.634381,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":69774913},{"date":"2025-10-10","current":-61.345797,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":73001499},{"date":"2025-10-17","current":-60.49848,"twenty":-8.238495,"median":-4.014996,"eighty":-1.061383,"marketCap":71993191},{"date":"2025-10-24","current":-68.463266,"twenty":-8.295661,"median":-4.014996,"eighty":-1.061383,"marketCap":81471286},{"date":"2025-10-31","current":-64.735068,"twenty":-8.295661,"median":-4.014996,"eighty":-1.061383,"marketCap":77034731},{"date":"2025-11-07","current":-65.073995,"twenty":-8.317462,"median":-4.014996,"eighty":-1.061383,"marketCap":77438054},{"date":"2025-11-14","current":-69.818974,"twenty":-8.317462,"median":-4.014996,"eighty":-1.061383,"marketCap":83084579},{"date":"2025-11-21","current":-117.35491,"twenty":-8.403551,"median":-4.014996,"eighty":-1.061383,"marketCap":70178236},{"date":"2025-11-28","current":-145.784813,"twenty":-8.440594,"median":-4.014996,"eighty":-1.061383,"marketCap":87179318},{"date":"2025-12-05","current":-132.719192,"twenty":-8.503786,"median":-4.014996,"eighty":-1.061383,"marketCap":79366077},{"date":"2025-12-12","current":-149.910798,"twenty":-8.562452,"median":-4.014996,"eighty":-1.061383,"marketCap":89646657},{"date":"2025-12-19","current":-128.593207,"twenty":-8.61847,"median":-4.014996,"eighty":-1.061383,"marketCap":76898738},{"date":"2025-12-26","current":-132.031528,"twenty":-8.683631,"median":-4.014996,"eighty":-1.061383,"marketCap":78954854},{"date":"2026-01-02","current":-112.089266,"twenty":-8.713986,"median":-4.014996,"eighty":-1.061383,"marketCap":67029381},{"date":"2026-01-09","current":-109.338609,"twenty":-8.744078,"median":-4.014996,"eighty":-1.061383,"marketCap":65384488},{"date":"2026-01-16","current":-121.716565,"twenty":-8.744078,"median":-4.014996,"eighty":-1.061383,"marketCap":72786506},{"date":"2026-01-23","current":-114.839923,"twenty":-8.776229,"median":-4.014996,"eighty":-1.061383,"marketCap":68674274},{"date":"2026-01-30","current":-107.275617,"twenty":-8.801379,"median":-4.014996,"eighty":-1.061383,"marketCap":64150819},{"date":"2026-02-06","current":-105.900288,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":63328372},{"date":"2026-02-13","current":-94.209997,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":56337578},{"date":"2026-02-20","current":-90.771676,"twenty":-8.824243,"median":-4.014996,"eighty":-1.061383,"marketCap":54281462},{"date":"2026-02-27","current":-89.396348,"twenty":-8.847106,"median":-4.014996,"eighty":-1.061383,"marketCap":53459016},{"date":"2026-03-06","current":-102.461967,"twenty":-8.978573,"median":-4.014996,"eighty":-1.061383,"marketCap":61272256},{"date":"2026-03-13","current":-112.089266,"twenty":-9.171771,"median":-4.014996,"eighty":-1.061383,"marketCap":67029381},{"date":"2026-03-20","current":-107.275617,"twenty":-9.560454,"median":-4.014996,"eighty":-1.061383,"marketCap":64150819},{"date":"2026-03-27","current":-65.812063,"twenty":-12.877976,"median":-4.014996,"eighty":-1.061383,"marketCap":66206935},{"date":"2026-04-02","current":-69.895519,"twenty":-13.201682,"median":-4.014996,"eighty":-1.061383,"marketCap":70314892},{"date":"2026-04-10","current":-72.347993,"twenty":-13.956876,"median":-4.014996,"eighty":-1.061383,"marketCap":72782081},{"date":"2026-04-17","current":-68.669281,"twenty":-14.862192,"median":-4.014996,"eighty":-1.061383,"marketCap":69081297},{"date":"2026-04-24","current":-67.85179,"twenty":-16.29052,"median":-4.014996,"eighty":-1.061383,"marketCap":68258901},{"date":"2026-05-01","current":-62.137525,"twenty":-17.553263,"median":-4.014996,"eighty":-1.061383,"marketCap":62510350},{"date":"2026-05-08","current":-58.041893,"twenty":-19.337667,"median":-4.014996,"eighty":-1.061383,"marketCap":58390144},{"date":"2026-05-15","current":-7.909727,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":60446135},{"date":"2026-05-22","current":-7.748304,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":59212540},{"date":"2026-05-29","current":-9.254919,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":70726090},{"date":"2026-06-05","current":-9.201111,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":70314892},{"date":"2026-06-12","current":-8.878265,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":67847703},{"date":"2026-06-18","current":-8.555419,"twenty":-19.74448,"median":-4.014996,"eighty":-1.061383,"marketCap":65380513},{"date":"2026-06-26","current":-8.609227,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":65791712},{"date":"2026-07-02","current":-9.954419,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":76071667},{"date":"2026-07-10","current":-8.017342,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":61268531},{"date":"2026-07-17","current":-6.887381,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":52633369},{"date":"2026-07-24","current":-5.811228,"twenty":-19.758995,"median":-4.013714,"eighty":-1.061345,"marketCap":44409405},{"date":"2026-07-31","current":-6.080266,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":46465396},{"date":"2026-08-07","current":-4.681267,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":35774243},{"date":"2026-08-14","current":-5.360858,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":40967676},{"date":"2026-08-21","current":-4.429377,"twenty":-19.773511,"median":-4.012432,"eighty":-1.061308,"marketCap":29610382},{"date":"2026-08-28","current":-3.937907,"twenty":-19.773511,"median":-4.010102,"eighty":-1.061308,"marketCap":26324908},{"date":"2026-09-02","current":-3.706627,"twenty":-19.691837,"median":-3.98705,"eighty":-1.061308,"marketCap":24778803}],"updateTime":1788493339161},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BYSI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640917836","title":"BeyondSpring says Phase 2 trial shows 7-month median PFS for pembrolizumab plus plinabulin/docetaxel in post-ICI metastatic NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2640917836","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640917836?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:03","pubTimestamp":1780398218,"startTime":"0","endTime":"0","summary":"BeyondSpring reported updated Phase 2 results at ASCO 2026 for pembrolizumab, plinabulin, docetaxel in metastatic NSCLC progressing on first-line ICI therapy.Data showed sustained tumor control with responses that generally held up over time in a post-ICI setting with limited options.Survival outcomes remained strong at 12 months and 24 months, with the study not yet reaching a midpoint survival estimate.Safety looked manageable, with a meaningful share of patients reporting serious treatment-related side effects, including blood count-related events.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL9Ldqrb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","SG9999014013.SGD","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","IE00BKPKM429.USD","BK4139","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4112","BYSI","SG9999014021.USD","IE00B3QW5Z07.USD","SG9999014039.USD","NDAQ","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640175949","title":"BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640175949","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640175949?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:00","pubTimestamp":1780398000,"startTime":"0","endTime":"0","summary":"Meaningful clinical benefit: Median PFS at 7.0 months, median DoR is 9.3 months with DCR of 79.5% in metastatic NSCLC patients with acquired resistance to immune checkpoint inhibitorsDurable survival ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3304984/0/en/BeyondSpring-Presents-the-Latest-Update-of-a-Phase-2-Study-Demonstrating-Durable-Clinical-Benefit-of-Pembrolizumab-Plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-After-Progression-o.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","PFS","AR","LU0210528500.USD","LU0053666078.USD","BK4213","BK4139","BK4107","L","BK4588","LU2487616109.SGD","BK4080","ORR","BK4195","BYSI","BK4585","BK4211","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027107","title":"BeyondSpring to present Phase 2 plinabulin combo study in resistant NSCLC at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027107","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027107?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:02","pubTimestamp":1779102157,"startTime":"0","endTime":"0","summary":"BeyondSpring flagged new Phase 2 data from Study 303 in metastatic non-small cell lung cancer patients whose disease progressed on PD-1/PD-L1 inhibitors, with results scheduled for future presentation at the 2026 ASCO Annual Meeting.The poster will cover efficacy and immune profiling for a regimen combining plinabulin, docetaxel, and pembrolizumab in second- or third-line treatment.Disclosure at ASCO is set for May 31, 2026, in a lung cancer session in Chicago.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL372zj5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BN0W2W23.USD","LU2095319765.USD","BK4585","BK4588","LU2210150020.SGD","SG9999014005.SGD","LU2210149790.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","NDAQ","BYSI","IE00B64PRP62.GBP","BK4112","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4139","IE00BKPKM429.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636027291","title":"BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2636027291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636027291?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:00","pubTimestamp":1779102000,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., May  18, 2026  (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatmen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/18/3296480/0/en/BeyondSpring-Announces-Poster-Presentation-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AR","BYSI","LU0053666078.USD","BK4585","BK4588","BK4213","LU2487616109.SGD","L","BK4107","BK4139","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635899347","title":"BeyondSpring Q1 EPS $(0.05) Up From $(0.06) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635899347","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635899347?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:23","pubTimestamp":1778671411,"startTime":"0","endTime":"0","summary":"BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.05) per share. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52518190/beyondspring-q1-eps-0-05-up-from-0-06-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","TQQQ","QYLG","PSQ","QQQE","MNQmain",".IXIC","GPIQ","QQQY","QID","QLD","ONEQ","JEPQ","IYW","NQmain","QQQA","QQQM","SQQQ","TQQY","NVIW.SI","QDTE","NDX","FTEC","QQQ","BK4139","QQQJ","TECS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786148","title":"BeyondSpring Q1 FY26 net loss narrows to $2.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786148","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786148?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:05","pubTimestamp":1778670305,"startTime":"0","endTime":"0","summary":"BeyondSpring posted a net loss of USD 2.4 million for the quarter ended March 31, 2026, narrowing from a net loss of USD 2.6 million a year earlier.R&D expenses rose 22.22% to USD 1.1 million, while G&A expenses dropped 35.29% to USD 1.1 million.Cash, cash equivalents, and short-term investments totaled USD 7.9 million as of March 31, 2026.Discontinued operations swung to a net loss of USD 4.3 million from net income of USD 3.8 million a year earlier; current assets were USD 5.3 million as of March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securiti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDLc34p7v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635869337","title":"BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635869337","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635869337?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"AACR 2026 Data Positions Plinabulin as a Potential Backbone Agent to Combine with Antibody-Drug Conjugate (ADC)-Based Therapies to Improve Anti-Cancer Efficacy and Tolerability SEED Advances First Mol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293842/0/en/BeyondSpring-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","BYSI","BK4139","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629076662","title":"BeyondSpring publishes corporate presentation on plinabulin immune-modulating cancer therapy pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2629076662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629076662?lang=en_us&edition=fundamental","pubTime":"2026-04-23 06:07","pubTimestamp":1776895622,"startTime":"0","endTime":"0","summary":"BeyondSpring investor deck highlighted plinabulin as lead late-stage asset, positioning it as a first-in-class, reversible tubulin depolymerizing agent with immune-modulating activity.DUBLIN-3 Phase 3 trial in 2L/3L NSCLC EGFR wild type reported overall survival benefit for plinabulin + docetaxel vs docetaxel, with OS HR 0.82.Study showed median OS 10.5 months for plinabulin + docetaxel vs 9.4 months for docetaxel.Safety readout cited grade 4 neutropenia reduction on day 8 across all cycles, with 22.3% on plinabulin + docetaxel vs 43.5% on docetaxel.Pipeline update flagged SEED targeted protein degradation platform, with lead oral RBM39 degrader entering Phase 1.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. publishe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL65Gq5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010045","title":"BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010045","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010045?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"New Preclinical Results at AACR 2026 Show Plinabulin Dramatically Improves Complete Response Rates and Survival When Combined with Leading ADC Drugs— With or Without Immunotherapy Plinabulin’s GEF-H1 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278803/0/en/BeyondSpring-Reports-Compelling-New-Data-Plinabulin-Advances-Both-the-Anticancer-Efficacy-and-Safety-of-ADC-Drugs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4080","BK4139","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623174314","title":"BeyondSpring to present plinabulin-ADC combination data at AACR annual meeting poster session","url":"https://stock-news.laohu8.com/highlight/detail?id=2623174314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623174314?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:31","pubTimestamp":1774870279,"startTime":"0","endTime":"0","summary":"BeyondSpring to present poster on plinabulin with antibody-drug conjugates at AACR Annual Meeting, held April 17-22, 2026 in San Diego.Poster presentation scheduled April 21, 2026 from 2 p.m. to 5 p.m. PT at San Diego Convention Center.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL8xdj2J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014021.USD","SG9999014039.USD","SG9999014013.SGD","BK4139","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","LU2095319765.USD","NDAQ","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","BYSI","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","BK4585","LU0314104364.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623129133","title":"BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2623129133","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623129133?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:30","pubTimestamp":1774870200,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., March  30, 2026 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264525/0/en/BeyondSpring-Announces-Plinabulin-and-ADC-Combination-Poster-Presentation-at-AACR-Annual-Meeting-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4080","BK4231","ADC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622738863","title":"BeyondSpring publishes IO360 Summit presentation on plinabulin; PD-1/L1 resistance highlighted","url":"https://stock-news.laohu8.com/highlight/detail?id=2622738863","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622738863?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:37","pubTimestamp":1774532272,"startTime":"0","endTime":"0","summary":"BeyondSpring published a presentation titled “Overcoming PD-1/L1 Resistance: Translational Insights with Plinabulin.”The presentation was posted as part of the 2026 IO360 Summit materials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief on March 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL4FjxmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622569858","title":"BeyondSpring publishes corporate presentation; plinabulin clinical program advances and SEED targeted protein degradation pipeline grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2622569858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622569858?lang=en_us&edition=fundamental","pubTime":"2026-03-26 18:21","pubTimestamp":1774520481,"startTime":"0","endTime":"0","summary":"BeyondSpring publishes corporate presentation; plinabulin clinical program advances and SEED targeted protein degradation pipeline grows. BeyondSpring outlined development plans for plinabulin, a small-molecule immune modulator positioned for use with docetaxel in later-line non-small cell lung cancer .In the global Phase 3 DUBLIN-3 study , plinabulin plus docetaxel reported median overall survival of 10.5 months versus 9.4 months for docetaxel, with a hazard ratio of 0.82.The presentation reported grade 4 neutropenia rates of 5.13% with plinabulin plus docetaxel versus 33.58% with docetaxel.BeyondSpring said the planned DUBLIN-4 confirmatory Phase 3 study will evaluate plinabulin plus docetaxel versus docetaxel in 2L/3L non-squamous NSCLC after PD-1/L1 progression, with a progression-free survival threshold of at least 3 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inf","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL48394s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622300212","title":"BeyondSpring FY2025 net loss drops 15% to $14 million; research and development expenses climb 66% to $4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622300212","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622300212?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:37","pubTimestamp":1774471045,"startTime":"0","endTime":"0","summary":"BeyondSpring published its annual report on Form 10-K for the fiscal year ended Dec. 31, 2025.Net loss was USD 14.2 million, compared with a 15% narrower loss year over year.R&D expense rose 66% to USD 4.4 million, driven by expanded drug manufacturing activities, increased NSCLC data management efforts, higher combination-therapy research to support partnering, higher regulatory professional services, and higher personnel costs.G&A expense fell 25% to USD 4.6 million, reflecting lower personnel costs from reduced headcount, lower business development and partnership consulting, and reduced corporate overhead including D&O insurance and investor marketing advisory expenses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring In","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL9sJKct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622110888","title":"BeyondSpring Files 2025 Annual Report on Form 10-K","url":"https://stock-news.laohu8.com/highlight/detail?id=2622110888","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622110888?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:30","pubTimestamp":1774470600,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., March  25, 2026 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage company developing transformative therapies for the treatme","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/25/3262607/0/en/BeyondSpring-Files-2025-Annual-Report-on-Form-10-K.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075254","title":"BeyondSpring Q4 EPS $(0.05)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075254","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075254?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:35","pubTimestamp":1774442134,"startTime":"0","endTime":"0","summary":"BeyondSpring (NASDAQ:BYSI) reported quarterly losses of $(0.05) per share.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51453963/beyondspring-q4-eps-0-05","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622307548","title":"BeyondSpring FY2025 operating loss narrows 2.25% to $8.7 million; R&D expenses jump 69.23% to $4.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622307548","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622307548?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:31","pubTimestamp":1774441898,"startTime":"0","endTime":"0","summary":"R&D expenses jumped 69.23% to $4.4 million on higher drug manufacturing, NSCLC data management, Plinabulin combination research, regulatory consulting, and personnel costs.G&A expenses fell 24.59% to $4.6 million on lower personnel costs, reduced consulting expenses, and lower corporate overhead.Cash, cash equivalents, and short-term investments totaled $12.6 million.Chief Executive Officer Lan Huang said the company remained focused on advancing the DUBLIN-4 confirmatory trial for Plinabulin in EGFR wild-type non-squamous NSCLC post immune checkpoint inhibitors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Anal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL7HRC0m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BYSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622075136","title":"Beyondspring Reports 2025 Year-End Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622075136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622075136?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nTUA90MXY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BYSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622107545","title":"Press Release: BeyondSpring Reports 2025 Year-End Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2622107545","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622107545?lang=en_us&edition=fundamental","pubTime":"2026-03-25 20:30","pubTimestamp":1774441800,"startTime":"0","endTime":"0","summary":"-- Phase 3 Survival Benefit Confirmed: Plinabulin combined with docetaxel. standard of care docetaxel in EGFR wild-type NSCLC patients whose tumors. progressed after first line therapy -- DUBLIN-3 study results published. discussions, BeyondSpring is advancing DUBLIN-4, a confirmatory global. Phase 3 study in a biomarker-selected EGFR wild-type NSCLC patient. sensitivity to checkpoint inhibitors -- a significant unmet need. Cell Press journal Med 2025 and presented at SITC 2025. \"2025 was a year of important clinical and operational progress for BeyondSpring and SEED Therapeutics,\" said Dr. Lan Huang, Co-Founder, Chairman and Chief Executive Officer of BeyondSpring. \"We advanced our Phase 3 Plinabulin program, generated meaningful clinical data, and strengthened our strategic and financial position.\". \"BeyondSpring made meaningful progress advancing Plinabulin in Phase 3 NSCLC, while SEED Therapeutics reached a critical milestone -- initiating its first clinical trial following IND cle","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BYSI","BK4097","OS","BK4225","BK4211","BK4195","BK4139","HR","ORR","BK4203","PFS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":39,"code":"91000000","status":"200"}]}}